Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erp, N. van"'
Autor:
Benoist, G.E., Oort, I.M. van, Smeenk, Stella, Javad, Adrian, Somford, D.M., Burger, D.M., Mehra, N., Erp, N. van
Publikováno v:
British Journal of Clinical Pharmacology, 84, 122-129
British Journal of Clinical Pharmacology, 84, 1, pp. 122-129
British Journal of Clinical Pharmacology, 84, 1, pp. 122-129
Contains fulltext : 181508.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b87bdac092edc5782db08e8b7c398db6
http://hdl.handle.net/2066/181508
http://hdl.handle.net/2066/181508
Publikováno v:
International Journal of Cancer, 138, 10, pp. 2312-21
International Journal of Cancer, 138, 2312-21
International Journal of Cancer, 138, 2312-21
Item does not contain fulltext Mammalian target of rapamycin inhibitors (mTORi) have clinically significant activity against various malignancies, such as renal cell carcinoma and breast cancer, but their use can be complicated by several toxicities.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c99d8081d175cc47d8b93921fe3ae2f
https://hdl.handle.net/2066/171991
https://hdl.handle.net/2066/171991
Autor:
Yu, H., Steeghs, N., Kloth, J.S., Wit, D. de, Hasselt, J.G. van, Erp, N. van, Beijnen, J.H., Schellens, J.H., Mathijssen, R.H., Huitema, A.D.
Publikováno v:
British Journal of Clinical Pharmacology, 79, 809-19
British Journal of Clinical Pharmacology, 79, 5, pp. 809-19
British Journal of Clinical Pharmacology, 79, 5, pp. 809-19
Item does not contain fulltext AIMS: Previously published pharmacokinetic (PK) models for sunitinib and its active metabolite SU12662 were based on a limited dataset or lacked important elements such as correlations between sunitinib and its metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cc5d5ab409026f7e92407f10f35ef007
http://hdl.handle.net/2066/153187
http://hdl.handle.net/2066/153187
Autor:
Erp, N. van, Graaf, W.T.A. van der
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 158, 0, pp. A7884
Nederlands Tijdschrift voor Geneeskunde, 158, A7884
Nederlands Tijdschrift voor Geneeskunde, 158, A7884
Item does not contain fulltext Oral tyrosine kinase inhibitors and mammalian target of rapamycin (mTOR) inhibitors are indicated in several types of cancer. They are usually administered at a fixed dose. In recent years, observational studies have re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::57c847f9a4c0ac110f9ee52a75982345
https://hdl.handle.net/2066/136166
https://hdl.handle.net/2066/136166
Autor:
Hulshof, E.C.
Publikováno v:
None
Colorectal cancer (CRC) is often treated with chemotherapy. However, it is well known that treatment with chemotherapy comes with challenges, such as (severe) adverse events leading to loss of quality of life, treatment discontinuation and sometimes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::38d3169561252c4e92ae2915f671620b
https://hdl.handle.net/1887/3619276
https://hdl.handle.net/1887/3619276
Autor:
Groenland, S L1 (AUTHOR), Sanchez-Spitman, A B2 (AUTHOR), Moes, D J A R2 (AUTHOR), Koolen, S L3 (AUTHOR), Dezentjé, V O4 (AUTHOR), Erp, N van5 (AUTHOR), Mathijssen, R H J6 (AUTHOR), Guchelaar, H-J2 (AUTHOR), Huitema, A D R7 (AUTHOR), Steeghs, N8 (AUTHOR)
Publikováno v:
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Autor:
Lankheet, N A G1 (AUTHOR), Ferrier, K R M1 (AUTHOR), Gibbons, S E2 (AUTHOR), Burger, D M1 (AUTHOR), McAllister, K2 (AUTHOR), Martin, J L M2 (AUTHOR), Khoo, S H2 (AUTHOR), Erp, N van1 (AUTHOR), Jansman, F G3 (AUTHOR)
Publikováno v:
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.